Navigation Links
Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
Date:7/15/2009

mercial potential for Acetavance; the possibility that the patent rights covering Acetavance may not be sufficient to preclude other intravenous formulations of acetaminophen from being developed by competitors; the potential for Cadence to require substantial additional funding in order to obtain regulatory approval for and commercialize Acetavance, and the risk that the company may not be able to raise sufficient capital when needed, or at all; and other risks detailed in Cadence's prior press releases as well as in Cadence's periodic public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Perfalgan is a registered trademark of Bristol-Myers Squibb Company.

    Contact:      William R. LaRue
                  SVP & Chief Financial Officer
                  Cadence Pharmaceuticals, Inc.
                  858-436-1400

                  Kate Weiss
                  Porter Novelli Life Sciences
                  617-897-8255
                  kweiss@pnlifesciences.com


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
5. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
6. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
8. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
(Date:7/13/2014)... Athletes with a certain genetic make-up are prone ... research presented today at the American Orthopaedic Society for ... marks the first of its kind investigating a genetic ... that occur after a head injury. , “We ... (GT)n genotype were four times more likely to have ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress manufacturer ... gorgeous Quinceanera dresses . , In ... outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving to ... released dresses are made according to the latest ... , It is worthy of mention that ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular ... has released its new range of elegant Quinceanera ... available at discounted prices. Worldwide clients can enjoy this ... the company’s online shop, there are plenty of beautiful ... with great materials. MyDressCity.com’s hot items are prom gowns, ...
(Date:7/13/2014)... Texas (PRWEB) July 13, 2014 Epidemiologists ... aGVHD in the 6MM, from 8,062 diagnosed incident cases ... at an Annual Growth Rate (AGR) of 4.35%, during ... the highest number of diagnosed incident cases of aGVHD ... Spain will have the lowest number of diagnosed incident ...
Breaking Medicine News(10 mins):Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4
... barrier to health care is unauthorized prescription drug switching, ... founder of the Minority Health Institute.In his keynote address ... Williams said the U.S. would be better served if ... patient,s needs without artificial barriers set by outside ...
... 28 This weekend, Americans will experience the stress-reducing ... ), a musical meditation that gets diverse groups of ... Heart of Rhythm and Sound," will take place on ... Rudramandir center, in Berkeley, California."Almost effortlessly, people with no ...
... Prevention efforts ,have run out of steam, expert says, , , ... risk of dying prematurely? Don,t smoke and keep a healthy ... about one in five deaths among U.S. adults, according to ... to be linked with premature death, the magnitude of the ...
... Monoxide Exposure Detection Following Disasters, Agency Unanimously Approves ... 28 Masimo (Nasdaq: ... Measure-Through Motion and Low-Perfusion pulse oximetry, announced today ... added to the Federal Emergency Management Agency,s (FEMA) ...
... Wash., April 28 Verathon(R) is pleased to announce ... Designed with Urologists in mind, the BVM 9500 ... quickly and noninvasively to help diagnose bladder dysfunction, including ... This new addition to the BladderScan(R) BVI 9000 ...
... of Our Society?TACOMA, Wash., April 28 What if ... looking to improve their lives can now prime their ... audio collection. The iDrug employs a technique called brain ... in order to "reprogram" their subconscious minds with new ...
Cached Medicine News:Health News:Barriers to Health Care, Prescription Choice Hurt Patients, Leading Doctor Says 2Health News:The Art of Rhythm Meditation: Zen Buddhist Goes Global with TaKeTiNa Rhythm Process 2Health News:1 in 5 U.S. Deaths Attributed to Smoking, High BP 2Health News:FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List 2Health News:FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List 3Health News:FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List 4Health News:FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List 5Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 2Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 3Health News:iDrug Technology Hopes to Promote Economic Stimulus at the Subconscious Level of Every Citizen 2
(Date:7/10/2014)... INC. (NYSE: RMD ) today announced that it ... 30, 2014 results on Thursday, July 31, 2014, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... Eppendorf expands its line of ... easy-to-use microcentrifuge features a certified aerosol-tight ... bowl design to reduce noise., ,Model ... offering optional rotors to accommodate microcentrifuge ...
The new BioZ Dx incorporates the world's most advanced impedance cardiography (ICG) technology and powerful reporting features to quickly and easily provide noninvasive hemodynamic parameters....
... Varicella-Zoster (VZ) test system is ... semi-quantitative detection of VZ IgG ... the indirect fluorescent antibody (IFA) ... or confirm a recent infection ...
Inquire...
Medicine Products: